NASDAQ:ZBIO - Nasdaq - US98937L1052 - Common Stock - Currency: USD
TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | ||||
---|---|---|---|---|---|---|
Revenue | 0.00 | 50.00M | 0.00 | |||
Operating Expenses | 133.04M | 77.15M | 75.20M | |||
Research and Development | 110.40M | 60.03M | 61.69M | |||
Selling, General, and Administrative Expenses | 22.64M | 17.11M | 13.51M | |||
Operating Income | -133.04M | -27.15M | -75.20M | |||
Other Income/Expense | 4.37M | 324.00K | -43.08M | |||
Non Recurring Items | N/A | -10.00M | -1.00M | |||
Income Before Taxes | -128.67M | -36.82M | -119.28M | |||
Income Tax | N/A | 301.00K | 0.00 | |||
Net Income | -128.97M | -37.12M | -119.28M | |||
EBITDA | -132.91M | -27.03M | -75.12M | |||
Per Share Data | ||||||
EPS Diluted Total Ops | -3.19 | -0.93 | -3.00 | |||
Statistics | ||||||
Profit Margin | N/A | -74.25% | N/A | |||
Operating Profit Margin | N/A | -54.29% | N/A |
All data in USD